Health Care/Hospital

YS Biopharma to Report First Nine Months of Fiscal Year 2024 Financial Results on April 19, 2024

GAITHERSBURG, Md., April 16, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious dise...

2024-04-16 20:00

CryptoLab Signs a Contract to Supply Cutting-Edge Homomorphic Encryption Technology to Macrogen

SEOUL, South Korea, April 16, 2024 /PRNewswire/ -- CryptoLab, a pioneer of fully homomorphic encryption (FHE) technology has announced the signing of a three-year supply contract with Macrogen, Korea's largest genetic data analysis company. This landmark agreement was a huge milestone of FHE tech...

2024-04-16 20:00

Exploring Pioneering Programs in Medical Integration in the Greater Bay Area: Actively Applying Digital Identity and Global Legal Entity Identifier (LEI)

HONG KONG, April 16, 2024 /PRNewswire/ -- With the rapid development in information technology, digital transformation has become a core driver in promoting the integration of various sectors in the Greater Bay Area (GBA). In the GBA, a pioneering program has been carried out to explore the poten...

2024-04-16 19:05 164

AUO Leads Micro LED Ecosystem Dream Team toward Unlocking New Advances in Diverse Field Applications

Cutting-Edge Technology Combined with Mass Production Capabilities to Create New Values across Verticals, from Smart Mobility to Retail and Healthcare HSINCHU, April 16, 2024 /PRNewswire/ -- Taiwan's display industry leads the world, continually integrating new and diverse applications into peopl...

2024-04-16 19:00 168

Wingderm® Shines Bright in the U.S.A., Continuously Expanding the Local Business Network

BALTIMORE, April 16, 2024 /PRNewswire/ -- Wingderm®, a medical aesthetic device service provider that offers comprehensive aesthetic solutions, recently concluded its successful participation in the AAD (American Academy of Dermatology) Annual Meeting in March and the ASLMS (American Society for ...

2024-04-16 17:22 441

Exyte acquires Kinetics Group to enhance global leadership in high-tech facility solutions

* Kinetics is a globally leading provider of installation services and equipment  * Company serves high-tech industries such as semiconductor, biopharma, and batteries  * 2,500 employees at more than 20 locations worldwide  * Exyte to enter technical facility management business  * Exyte...

2024-04-16 17:00 520

Fundiin Partners with Medpro to Launch BNPL at Over 200 Hospitals and Medical Centers

HO CHI MINH,  Vietnam, April 16, 2024 /PRNewswire/ -- On April 11, 2024, Fundiin and Medpro held a signing ceremony to celebrate their strategic partnership, marking the inaugural launch of a Buy Now Pay Later (BNPL) payment method at over 200 hospitals ...

2024-04-16 14:00 667

IHH Healthcare Selects Oracle Exadata Platform to Improve Operational Efficiency and Patient Outcomes

One of the world's largest integrated healthcare providers harnesses the power of cloud acrossSingapore and Malaysia to improve operational efficiency SINGAPORE, April 17, 2024 /PRNewswire/ -- Oracle CloudWorld Tour Singapore -- IHH Healthcare (IHH), a world-leading integrated healthcare provide...

2024-04-16 12:00 654

Value innovations address health concerns amid rising costs

AUCKLAND, New Zealand, April 16, 2024 /PRNewswire/ -- Four in 10 consumers worldwide find health and wellbeing nutritional products too expensive, with one-third of users saying that rising costs have made it hard to continue purchasing them. Despite feeling the pinch, health and wellbeing still...

2024-04-16 10:00 613

Innovent Announces the Appointment of Dr. Nageatte Ibrahim as the Oncology Chief Medical Officer (CMO)

SAN FRANCISCO and SUZHOU, China, April 16, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major dis...

2024-04-16 08:00 791

TLX101-CDx (Pixclara™) Granted FDA Fast Track Designation

* FDA Fast Track designation granted for TLX101-CDx for glioma (brain cancer) imaging * Collaboration agreement announced for joint development and commercialisation with UCSF * PharmaLogic announced as commercial manufacturing and pharmacy distribution partner MELBOURNE, Australia, April 1...

2024-04-16 06:42 696

【C.S】Cordyceps Sunshine has extended its market footprint in the world's largest traditional Chinese herbal medicine market with the introduction of their Cinnamomum product line.

TAIPEI, April 16, 2024 /PRNewswire/ -- Cordyceps Sunshine Group【C.S】Group, having recently achieved a successful U.S. IPO, hosted the '2024 China International Biomedical Innovation Development Conference and Chinese Rare Medicinal Herbs Cinnamomum Industry Transformation and Upgrade Conference' ...

2024-04-16 06:00 883

Pre-clinical result of LP-005, a novel bi-functional complement antibody-fusion protein was unveiled by LongBio at WCN2024

BUENOS AIRES, Argentina, April 15, 2024 /PRNewswire/ -- LongBio Pharma (Suzhou) Co., Ltd. (referred to as "LongBio"), a leading biotech company dedicated to developing innovative protein treatments for nephrology, allergy, respiratory, hematology, ophthalmology, and other autoimmune and rare dise...

2024-04-16 02:00 751

89th CMEF in Shanghai Elevates Global Medical Device Trade to The Next Level

SHANGHAI, April 15, 2024 /PRNewswire/ -- The 89th edition of the China International Medical Equipment Fair (CMEF) witnessed an impressive turnout of over 200,000 attendees from more than 150 countries. Prominent companies in the industry seized the opportunity to sho...

2024-04-15 21:00 907

First patient treated in Actinogen's XanaMIA phase 2b Alzheimer's disease trial

Plus, Actinogen receives approval of its application for a UK Innovation Passport as part of the Innovative Licensing and Access Pathway (ILAP) for Xanamem in the treatment of Alzheimer's disease Enrolment in XanaCIDD phase 2a trial of cognitive impairment and depression has surpassed 90% SYDNE...

2024-04-15 20:30 844

Wound Care Plus, LLC Revolutionizes Wound Management with ARANZ Medical's Silhouette Solution

CHRISTCHURCH, New Zealand, April 15, 2024 /PRNewswire/ -- Wound Care Plus, LLC, a leading provider of mobile wound care services in the US, has announced a groundbreaking partnership with ARANZ Medical to integrate ARANZ Medical's innovative Silhouette wound assessment solution into their wound c...

2024-04-15 20:00 645

TREEFROG PRESENTS DATA FROM THEIR PARKINSON'S CELL THERAPY PROGRAM AT THE AMERICAN ACADEMY OF NEUROLOGY ANNUAL MEETING

TreeFrog Therapeutics reports on the first bioproduction of a cell therapy for Parkinson's Disease in a scalable bioreactor1 BORDEAUX, France, April 15, 2024 /PRNewswire/ -- TreeFrog Therapeutics, a cell therapy development company with its lead program in Parkinson's Disease is presenting for t...

2024-04-15 15:30 774

GenScript Biotech officially joins SBTi to fulfill its sustainability commitment

PISCATAWAY, N.J., April 15, 2024 /PRNewswire/ -- On April 15, GenScript Biotech Corporation ("GenScript"), a world's leading technology and service provider of life science R&D and manufacture, announced that it has joined The Science Based Targets initiative (SBTi) and submitted the Science Base...

2024-04-15 15:04 709

NEW HEALTH RESORT BY CLINIQUE LA PRAIRIE TO OPEN IN TRI VANANDA, PHUKET

New Wellness Residential Community and Resort on the Forefront of Luxury Multi-Generational Living and Longevity PHUKET, Thailand, April 15, 2024 /PRNewswire/ -- Clinique La Prairie and Montara Hospitality Group are delighted to announce their partnership and the opening of a new Health Resort b...

2024-04-15 14:50 853

DIGITAL THERAPEUTICS STARTUP RESPIREE™ ANNOUNCES INCORPORATION IN US WITH RESIDENCY AT JLABS @ SAN FRANCISCO

SINGAPORE, April 15, 2024 /PRNewswire/ -- Respiree announced today that it has incorporated in the US and will be incubating within Johnson & Johnson Innovation – JLABS @South San Francisco[1] from February 12, 2024. By expanding footprint within the US, Respiree aims to deepen its relationships ...

2024-04-15 14:15 788
12345 ... 805